|
WO2021055638A1
|
|
Radiolabeling of anti-cd45 immunoglobulin and methods of use thereof
|
|
WO2020219928A1
|
|
Compositions and methods of immunodepletion for the treatment of malignant and non-malignant hematological diseases
|
|
WO2020219861A1
|
|
Compositions and methods of immunodepletion for the treatment of malignant and non-malignant hematological diseases
|
|
WO2020142583A1
|
|
Methods for treating cancer using combinations of parp inhibitors and antibody radioconjugates
|
|
WO2020159656A1
|
|
Molecules and their derivatives directed against cd45
|
|
WO2020132672A1
|
|
Combination of radioimmunotherapy and immune checkpoint therapy in the treatment of cancer
|
|
WO2020113047A1
|
|
Antibodies conjugated with actinium-225 and actinium-227, and related compositions and methods
|
|
EP3740235A1
|
|
Combination immunotherapy and chemotherapy for the treatment of a hematological malignancy
|
|
EP3720559A1
|
|
Methods for treatment of patients with myelodyplastic syndromes
|
|
EP3706785A1
|
|
Combination therapy for treatment of a hematological disease
|
|
WO2019084240A1
|
|
Methods for cancer treatment using a radiolabeled anti-cd45 immunoglobulin and adoptive cell therapies
|
|
CN111050796A
|
|
Treatment of hematologic malignancies
|
|
CA3059752A1
|
|
Method for treating cancer using a bcl-2 inhibitor in conjunction with an alpha-emitting radioimmunotherapeutic
|
|
US2019263903A1
|
|
Low dose antibody-based methods for treating hematologic malignancies
|
|
EP3426305A1
|
|
Stabilized radiolabeled anti-cd45 immunoglobulin compositions
|
|
EP3297684A1
|
|
Infusion administration of conjugated monoclonal antibodies
|
|
CN102596258A
|
|
Methods for generating radioimmunoconjugates
|
|
EP2082071A1
|
|
Method for the purification of radium from different sources
|
|
DE102006042191A1
|
|
Process for the purification of radium from various sources
|
|
DE102006008023A1
|
|
Method of cleaning 225Ac from irradiated 226Ra targets
|
